Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Moderna, Inc. (MRNA) vs Invesco Preferred ETF (PGX) Price & Performance

Moderna, Inc.Trade
Invesco Preferred ETFTrade

Price performance (Past 24H)

Key statistics

Moderna, Inc. vs Invesco Preferred ETF — how do they compare? Moderna, Inc. trades at $60.83 (market cap $24.18B), while Invesco Preferred ETF trades at $10.64. The key difference: Moderna, Inc. is trading nearer its 52-week high, Invesco Preferred ETF nearer its low. Which is the better fit depends on your goals.

MRNAPGX
Market Cap
$24.18B
Sector
Health
52-Week High
$81.80$11.87
52-Week Low
$22.36$10.65
Enterprise Value
$20.33B

Returns comparison

Trailing returns across standard periods

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA

About Invesco Preferred ETF

The fund generally will invest at least 80% of its total assets in the components of the index. Strictly in accordance with its guidelines and mandated procedures, ICE Data Indices, LLC selects securities for the index, which is a market capitalization-weighted index designed to measure the performance of the fixed rate US dollar-denominated preferred securities market.

Read more on PGX